Functional Cell Line Commercial License Support

As an essential tool in biopharmaceutical research and development, functional cell lines offer stability, broad applicability, and rich biological characteristics, making them extensively used in target validation, mechanism exploration, high-throughput drug screening, analytical testing, quality control (QC)  release, as well as pharmacodynamics and toxicology studies.

In the biopharmaceutical development process, obtaining commercial licensing for functional cell line products is a critical prerequisite to ensure the legal and compliant advancement of projects. This process not only safeguards intellectual property rights but also facilitates the smooth progression of research and development activities within the regulatory framework.

ACROBiosystems has officially secured global commercial usage rights for HEK293, CHO, Jurkat, Raji cell lines, enabling it to provide comprehensive licensing support and services worldwide. This strategic achievement significantly enhances ACROBiosystems' portfolio of functional cell line products and services, offering biopharmaceutical developers and CRO/CDMO partners robust regulatory and intellectual property assurance. By offering this critical support, ACROBiosystems empowers its partners across the entire drug development process—from early-stage research and regulatory submissions to successful commercialization — ensuring a seamless and compliant pathway for innovation and market entry.

ACROBiosystems' functional cell line license support service is designed to assist biopharmaceutical developers and CRO/CDMO partners in obtaining commercial licenses for cell line products in a legally compliant manner. From the outset of a project, this service helps customers mitigate intellectual property and compliance risks, ensuring the use of properly authorized cell lines. By preventing the utilization of unclear or unauthorized cell lines, it safeguards against potential disruptions to commercialization and technology transfer, which could otherwise result in significant financial and operational setbacks. Moreover, this service contributes to accelerating drug development timelines and reducing associated costs, enabling partners to focus on innovation and expediting the journey from research to market.

• Clear Cell Line Origin: ACRO’s cell line products are sourced from globally recognized and authoritative cell banks, ensuring clear and traceable origins. Comprehensive documentation is available to support global regulatory filings and project transfers, enabling customers to meet compliance requirements with confidence.

• Well-Defined Intellectual Property (IP) Rights: ACRO’s cell lines are formally licensed from original rights holders, granting ACRO the authority to modify, develop, and commercialize related products. The modified cell lines have clear IP ownership, and ACRO holds the rights to further authorize these cell lines. Customers using ACRO’s cell lines for drug development, regulatory submissions, or project transfers can eliminate future IP-related risks, ensuring a secure and compliant pathway for their projects.

• Global Commercial Authorization Support: ACRO’s dedicated international IP and legal team provides end-to-end support to help customers secure global commercial usage rights for cell line products. This ensures smooth regulatory compliance worldwide, enabling customers to navigate complex legal landscapes and accelerate their drug development processes with peace of mind.